Skip to main content
Log in

The history of development of fluorescence diagnosis and photodynamic therapy and their capabilities in oncology

  • Supplement: Rossiiskii Khimicheskii Zhurnal-Zhurnal Rossiiskogo Khimicheskogo Obshchestva im. D.I. Mendeleeva (Russian Chemistry Journal)
  • Published:
Russian Journal of General Chemistry Aims and scope Submit manuscript

Abstract

The main steps of development of fluorescence diagnosis and photodynamic therapy were overviewed. Brief historical data were presented about Photohem, Photosens, Alasens, Radachlorin, and Photoditazine photosensitizers, along with their corresponding pharmacokinetic properties, mechanisms of action, and specific features of use. Key aspects of development of fluorescence diagnosis and photodynamic therapy in Gertsen Moscow Research Oncological Institute were described. The main indications for photodynamic therapy and its efficiency in patients with oral, tongue, stomach, esophageal, skin, cervical, and central lung cancer and vulval lesions were demonstrated. It was shown that photodynamic therapy is effective for adjuvant or intraoperative treatment in patients with high risk of local recurrence after surgical treatment, and palliative photodynamic therapy increases the quality of life and survival rates in the most challenging group of cancer patients. The results of photodynamic therapy for cervical pre-cancer and cancer associated with human papillomavirus were reported. The main trends of intraoperative “fluorescence guidance” with Alasens were covered. Clinical experience allows rating photodynamic therapy among the most encouraging methods for the current medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Raab, O., Z. Biol., 1900, vol. 39, pp. 524–546.

    CAS  Google Scholar 

  2. Tappeiner, H., Muench. Med. Wochenschr., 1900, vol. 47, pp. 5–7.

    Google Scholar 

  3. Tappeiner, H. and Jesionek, H., Muench. Med. Wochenschr., 1903, vol. 50, pp. 2042–2044.

    Google Scholar 

  4. Policard, A., Compt. Rend. Soc. Biol., 1924, vol. 91, pp. 1423–1424.

    Google Scholar 

  5. Auler, H. and Banzer, G., Z. Krebsforsch., 1942, vol. 53, pp. 65–68.

    Article  CAS  Google Scholar 

  6. Lipson, R.L., Baldes, E.J., and Olsen, A.M., Dis. Chest., 1964, vol. 46, pp. 676–679.

    Article  CAS  Google Scholar 

  7. Lipson, R.L., Pratt, J.H., Baldes, E.J., and Dockerty, M.B., Obstet. Cynecol., 1964, vol. 24, pp. 78–84.

    CAS  Google Scholar 

  8. Dougherty, T.J., Kaufman, J.E., Goldfarb, A., Weishaupt, K.R., Boyle, D., and Mittleman, A., Cancer. Res., 1978, vol. 38, pp. 2628–2635.

    CAS  Google Scholar 

  9. Sukhin, G.M., Chernenko, O.V., and Yartsev, E.I., Abstract of Papers, Vsesoyuznaya konferentsiya po khimii i primeneniyu porfirinov (IV All-Union Conf. on Chemistry and Application of Porphyrins), Yerevan, 1984, pp. 230–231.

    Google Scholar 

  10. Filonenko, E.V., Doctoral (Med.) Dissertation, Moscow, 2006.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. V. Filonenko.

Additional information

Original Russian Text © E.V. Filonenko, 2013, published in Rossiiskii Khimicheskii Zhurnal, 2013, Vol. 57, No. 2, pp. 5–9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Filonenko, E.V. The history of development of fluorescence diagnosis and photodynamic therapy and their capabilities in oncology. Russ J Gen Chem 85, 211–216 (2015). https://doi.org/10.1134/S1070363215010399

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1070363215010399

Keywords

Navigation